Ebola disease outbreaks are major public health events because of human-to-human transmission and high mortality. These outbreaks are most often caused by Ebola virus, but at least three related viruses can also cause the disease. In 2022, Sudan virus re-emerged causing more than 160 confirmed and probable cases. This report describes generation of a recombinant Sudan virus and demonstrates its utility by quantifying antibody cross-reactivity between Ebola and Sudan virus glycoproteins after human infection or vaccination with a licensed Ebola virus vaccine.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623891 | PMC |
| http://dx.doi.org/10.1080/22221751.2023.2265660 | DOI Listing |
Publication Analysis
Top Keywords
sudan virus
20
recombinant sudan
8
cross-reactivity ebola
8
ebola sudan
8
virus glycoproteins
8
ebola virus
8
virus
7
ebola
5
virus evaluation
4
evaluation humoral
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!